Carnevale Alessia

Nata a Caserta (CE) il 25.9.1981.Laurea in Medicina e Chirurgia presso Facolta di Medicina e Chirurgia 'Sapienza' Università di Roma con votazione finale di 110/110 e lode in data 31/3/2008.Iscrizione presso Albo dei medici ed Odontoiatri presso Albo dei medici di Frosinone. Laurea specialistica in Radioterapia presso Facoltà di Medicina e Psicologia Azienda Ospedaliera Sant'Andrea 'Sapienza' Università di Roma con votazione finale 70/70 e lode in data 30/6/2014.

Dal 1/9/2014 Dirigente Medico presso Reparto di Radioterapia Oncologica presso il Policlinico Universitario Campus Biomedico di Roma. Dal 1/1/2019 Membro del PDTA patologia mammaria in qualità di specialista in Radioterapia oncologica presso Ospedale Sandro Pertini - ASL Roma 2. Partecipazione a diversi corsi e congressi in ambito sanitario, in particoalre in ambito Oncologico e della Radioterapia. Membro di società scientifiche: AIRO, AIOM, SIURO, ESTRO

1.D'Amico et al. Radiomics-based prediction of overall survival in lung cancer using different volumes-of-interest. Applied Sciences Volume 10, Issue 18, September 2020, Article number 6425.

2.18F- Choline PET/CT Driven Salvage Radiotherapy in Prostate Cancer Patients: Up-Date Analysis wiyh 5-years Median Follow up. RM.D’Angelillo et al Radiol Med.2020 Jul;125(7):668-673.

3.Effects of ionizing radiation on bio-active plant extraxts useful for preventing oxidative damages. Mulinacci N et al G.vNat Prod Res. 2018 Apr 2:1-9

4.Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).Mercadante Set al IOPS MS study group.Adv Ther. 2017 Jan;34(1):120-135.

5.Multifraction radiotherapy for palliation of painful bone metastases: 20 Gy versus 30 Gy. Valeriani M et al. Tumori. 2015 May-Jun;101(3):318-22. M

6.Severe and Prolonged Myelosuppression during Concomitant Temozolomide and Radiotherapy Treatment in a Patient with Glioblastoma Multiforme. Claudia Scaringi et al

7.Role of salvage stereotactic body radiation therapy in post-surgical loco-regional recurrence in a selected population of non-small cell lung cancer patients. Agolli Let al Anticancer Res. 2015 Mar;35(3):1783-9.

8.Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings. Mercadante S et al ; IOPS Study Group. Clin J Pain. 2015 Mar;31(3):214-21.

9.Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results. Valeriani M, Carnevale A et al. Radiat Oncol. 2014 Sep 26;9:214.

10.Image-guided hypofractionated radiotherapy in low-risk prostate cancer patients. Valeriani M, Carnevale A, et al. Biomed Res Int. 2014;2014:465175.

11.Hypofractionated intensity-modulated simultaneous integrated boost and image-guided radiotherapy in the treatment of high-risk prostate cancer patients: a preliminary report on acute toxicity. Valeriani M, Carnevale A, et al. Tumori. 2013 Jul-Aug;99(4):474-9.

12.Clinical outcomes of single dose stereotactic radiotherapy for lung metastases. Osti MF, Carnevale A, et al. Clin Lung Cancer. 2013 Nov;14(6):699-703.

13. Radiation therapy after breast reconstruction: outcomes, complications, and patient satisfaction. Carnevale A, et al. Radiol Med. 2013 Oct;118(7):1240-50.

14. Exclusive electron intraoperative radiotherapy in early-stage breast cancer: a monoinstitutional experience. Osti MF, Carnevale et al RM. Anticancer Res. 2013 Mar;33(3):1229-35.